Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26841662 | 0.89 | TSHR (0.50) | TSHRHCAR2HPGDLMNAALDH1A1 | |
| SCHEMBL1789613 | 0.80 | TSHR (0.43) | TSHRHCAR2HPGDALDH1A1TP53 | |
| SCHEMBL8965914 | 0.79 | TSHR (0.46) | TSHRHCAR2HPGDLMNAALDH1A1 | |
| SCHEMBL1284885 | 0.79 | TSHR (0.46) | TSHRHCAR2HPGDLMNAALDH1A1 | |
| SCHEMBL14877596 | 0.78 | TSHR (0.42) | TSHRHCAR2HPGDLMNAALDH1A1 | |
| SCHEMBL28245096 | 0.78 | TSHR (0.42) | TSHRHCAR2HPGDLMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL15641108 | 0.77 | TSHR (0.45) | TSHRHCAR2HPGDALDH1A1TP53 | |
| SCHEMBL1374266 | 0.77 | TSHR (0.45) | TSHRHCAR2HPGDALDH1A1TP53 | |
| Ammonia Solution, Strong SCHEMBL28352250 | 0.77 | TSHR (0.45) | TSHRHCAR2HPGDALDH1A1TP53 | |
| SCHEMBL8966172 | 0.77 | TSHR (0.45) | TSHRHCAR2HPGDALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092188-A1 | Radiation Curable Ink Composition For Ink Jet And Ink Jet Recording Method | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20260092190-A1 | Radiation Curable Ink Composition For Ink Jet And Recording Apparatus | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092190-A1 | Radiation Curable Ink Composition For Ink Jet And Recording Apparatus | KAT8, TAS2R8, NLRP3 | TSHR 3114/4885HCAR2 3153/4885HPGD 2630/4885 |
| US-20260092188-A1 | Radiation Curable Ink Composition For Ink Jet And Ink Jet Recording Method | JAK1, EED, PI4KA | TSHR 4124/4885HCAR2 2420/4885HPGD 1461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.